ADARx Pharmaceuticals, Inc. (NASDAQ:ADRX)
| Market Cap | 2.00B+1.0% |
| Revenue (ttm) | n/a |
| Net Income | n/a |
| EPS | n/a |
| Shares Out | 102.20M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 950,437 |
| Open | 20.68 |
| Previous Close | 19.94 |
| Day's Range | 18.99 - 20.72 |
| 52-Week Range | 18.50 - 23.21 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
ADARx Pharmaceuticals, Inc. has a live Insider Score.
Scored on 10 qualifying trades from 4 insiders in the last 90 days.
About ADRX
ADARx Pharmaceuticals, Inc. is a late-clinical-stage biotechnology company. It focuses on developing next-generation small interfering RNA (siRNA) therapeutics for diseases with significant unmet medical needs. The company was founded by Zhen Li in December 2019 and is headquartered in San Diego, CA.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
$ADRX stock is featured in our Insider Score Rankings, and Insider Trades datasets.
→ All Stock ListsRecently reported changes in ADRX holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by ADRX's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
ADRX Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New ADRX patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to ADRX from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in ADRX
| ETF | Est. Holding Size |
|---|---|
| TMEDT. Rowe Price Exchange-Traded Funds, Inc. - T. Rowe Price Health Care ETF | $43.91K |
| TDNAT. Rowe Price Biotech ETF | $19.64K |
| TSEET. Rowe Price Small Cap ETF | $8.79K |
Estimated from each fund’s disclosed top holdings × AUM
ADRX Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from ADRX’s recent data — informational, not investment advice
Insider Score
Our 0–100 Insider Score and the signals behind it.
The live Insider Score and its full factor breakdown are included with Insider Access.
Unlock Insider Score